Clinical Trial Update: When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study) [Phase 3]

View source ↗

Summary

The Phase 3 PREDICT trial evaluating when to start antiretroviral therapy in children with HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED